Nutra Pharma Corp (NPHC) Assets Average (2011 - 2026)

Nutra Pharma has disclosed Assets Average across 15 years of filings, most recently posting $619690.5 for Q2 2026.

• In Q2 2026, Assets Average fell 24.16% year-over-year to $619690.5; the TTM figure through Jun 2026 stood at $619690.5 (down 24.16% YoY), while the FY2025 annual figure was $611048.0, down 1.44% from the prior year.
• Assets Average came in at $619690.5 for Q2 2026 at Nutra Pharma, roughly flat from $619559.5 in the prior quarter.
• In the past five years, Assets Average ranged from a high of $817123.5 in Q2 2025 to a low of $579166.5 in Q4 2024.
• Average Assets Average over 5 years is $694316.1, with a median of $705061.2 recorded in 2022.
• Year-over-year, Assets Average jumped 111.2% in 2022 and slipped 24.16% in 2026.
• Over 5 years, Assets Average stood at $722785.5 in 2022, then decreased by 6.49% to $675867.5 in 2023, then dropped by 14.31% to $579166.5 in 2024, then increased by 15.03% to $666227.0 in 2025, then dropped by 6.99% to $619690.5 in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $619690.5 in Q2 2026, $619559.5 in Q1 2026, and $666227.0 in Q4 2025.